1. Home
  2. DERM vs MSLE Comparison

DERM vs MSLE Comparison

Compare DERM & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DERM

Journey Medical Corporation

HOLD

Current Price

$6.40

Market Cap

135.3M

Sector

Health Care

ML Signal

HOLD

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$7.30

Market Cap

146.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
DERM
MSLE
Founded
2014
N/A
Country
United States
Canada
Employees
N/A
17
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
135.3M
146.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DERM
MSLE
Price
$6.40
$7.30
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$12.67
N/A
AVG Volume (30 Days)
256.8K
25.0K
Earning Date
05-13-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
34.72
N/A
EPS
N/A
N/A
Revenue
$61,858,000.00
N/A
Revenue This Year
$39.72
N/A
Revenue Next Year
$63.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10.20
N/A
52 Week Low
$4.31
$5.50
52 Week High
$9.56
$13.39

Technical Indicators

Market Signals
Indicator
DERM
MSLE
Relative Strength Index (RSI) 64.73 49.89
Support Level $4.84 $6.73
Resistance Level $6.71 $8.59
Average True Range (ATR) 0.40 0.48
MACD 0.08 0.00
Stochastic Oscillator 85.90 38.27

Price Performance

Historical Comparison
DERM
MSLE

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: